Nu Skin Enterprises, Inc.
NUS
$8.20
-$0.18-2.15%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -18.19% | 3.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.19% | 3.58% | |||
| Cost of Revenue | -7.90% | -0.84% | |||
| Gross Profit | -22.33% | 5.47% | |||
| SG&A Expenses | -19.07% | 1.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.62% | 0.50% | |||
| Operating Income | -51.86% | 73.30% | |||
| Income Before Tax | 332.87% | -534.67% | |||
| Income Tax Expenses | 224.84% | -534.29% | |||
| Earnings from Continuing Operations | 397.78% | -534.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 397.78% | -534.90% | |||
| EBIT | -51.86% | 73.30% | |||
| EBITDA | -38.77% | 35.14% | |||
| EPS Basic | 397.47% | -534.91% | |||
| Normalized Basic EPS | -56.76% | 102.09% | |||
| EPS Diluted | 394.64% | -534.91% | |||
| Normalized Diluted EPS | -57.27% | 102.21% | |||
| Average Basic Shares Outstanding | 0.10% | 0.01% | |||
| Average Diluted Shares Outstanding | 1.24% | -0.04% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.34% | -1.23% | |||